This bill establishes a formal legal framework for supported decision-making, allowing adults to voluntarily enter into written agreements with trusted supporters to help them make life decisions without losing their legal autonomy. It mandates that the state create a training program for supporters and decision-makers covering their rights, obligations, and dispute resolution processes. Additionally, the bill requires schools to inform students with disabilities and their families about this option as an alternative to guardianship when the students turn sixteen. By adding supported decision-making agreements to existing guardianship laws, the legislation aims to provide a flexible, self-determined way for adults to receive assistance while retaining control over their own lives.
This bill authorizes adults with disabilities in Massachusetts to enter into supported decision-making agreements as an alternative to traditional guardianship. It requires the state to create a training program for supporters and decision-makers and mandates that schools inform students with disabilities about this option when they turn sixteen. The legislation defines the roles of supporters and decision-makers, outlines the rights and obligations of each party, and establishes rules for dispute resolution while ensuring the decision-maker retains full control over their life choices.
This bill appears to be a procedural document rather than a substantive legislative proposal, as it lacks specific policy provisions or new rules. The text references existing sections of the 1981 acts and Chapter 3 of the General Laws without introducing any new requirements or changes. Consequently, there are no direct effects on individuals, organizations, or government operations to describe.
Senate, October 19, 2023 -- The committee on Labor and Workforce Development, to whom was referred the petitions (accompanied by bill, Senate, No. 1166) of Ryan C. Fattman, Joseph D. McKenna, Brian M. Ashe, Alyson M. Sullivan-Almeida and other members of the General Court for legislation to ensure domestic violence victims' protections for all employees in the Commonwealth; and (accompanied by bill, House, No. 1919) of Joseph D. McKenna, Ryan C. Fattman and others relative to employment protections for domestic violence victims, reports the accompanying bill (Senate, No. 2479).
This bill serves as a formal record of a report submitted by the Department of Public Health regarding Eastern Equine Encephalitis and other arboviruses for July 2024. The document provides data on recent animal cases and includes details on public awareness campaigns aimed at informing the community about these health risks. By placing this briefing on file, the legislation ensures that the state's current epidemiological data is officially archived for public and governmental review.
This document is a weekly report from the Massachusetts Department of Public Health that provides data on mosquito-borne viruses like West Nile and eastern equine encephalitis. It details the number of positive virus samples found in mosquitoes, animals, and humans across various counties, noting that risk levels have been raised in several areas due to recent detections. The report also outlines public health recommendations, such as using EPA-registered repellents and removing standing water, to help residents reduce their exposure to these viruses.
Report of the Massachusetts Life Insurance Community Investment Initiative (pursuant to Section 2(e) of Chapter 259 of the Acts of 1998) submitting its 2023 annual report and statement of financial condition
Report of the Massachusetts Technical Rescue Coordinating Council (pursuant to Section 2DDDDD of Chapter 29 of the General Laws) submitting its fiscal year 2024 annual report
Senate, August 8, 2024 -- The committee on The Judiciary, to whom was referred the petitions (accompanied by bill, Senate, No. 982) of Cindy F. Friedman, Michael J. Barrett, Joanne M. Comerford, Sal N. DiDomenico and other members of the Senate for legislation relative to treatment, not imprisonment; and (accompanied by bill, House, No. 1391) of Ruth B. Balser and others relative to court considerations of persons having alcohol or substance use disorders and needing treatment, report the accompanying bill (Senate, No. 2927).
This bill strengthens safety and justice measures by expanding access to social services for indigent defendants and improving compensation for those convicted of crimes in error. It requires the state to connect eligible clients with vendors for post-release support and lowers the legal standard of proof for wrongful conviction claims from "clear and convincing" to "a preponderance of the evidence." The legislation also establishes specific monetary caps for damages awarded to claimants, authorizes courts to order expungement of criminal records for erroneous convictions, and introduces stricter penalties for tampering with GPS monitoring devices used during probation or parole. Additionally, it updates the criteria for pretrial detention to include certain repeat offenses and violations of specific protective orders.
This bill directs the Department of Correction to submit a report detailing the operational capacity of Massachusetts sheriff facilities for the first half of 2024. The document provides a breakdown of available and occupied housing units, including specific data on bed counts, prisoner populations by gender and status, and facility conditions across various counties. By placing this report on file, the legislation ensures that the state maintains a record of current jail and prison space utilization without altering any existing laws or policies.
This document is a formal report submitted by the Massachusetts Executive Office of Health and Human Services to state legislative committees regarding MassHealth pharmacy costs. It details the projected expenses for 68 new pharmaceutical products expected to become available between April 1, 2024, and March 31, 2025, estimating a total cost of approximately $13.9 million. The report highlights that cell and gene therapies account for about 70% of this spending, noting a decrease from the previous quarter's estimate due to the approval of two specific gene therapies.
